Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Effects of high concentrations of progesterone and Mifepristone: a gene expression study of endometrial cancer cells

ABSTRACT: Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel -impregnated intrauterine device. Antiproliferative effect has also been reported after application of an anti-progestin impregnated intrauterine device which showed to induce endometrial atrophy. The intention of the present study was to obtain more information of novel therapeutic targets for hormonal treatment in endometrial hyperplasia and endometrial cancers. Gene expression of signaling pathways after stimulation of Ishikawa cells with high doses of progesterone (10 μM) or Mifepristone (10 μM) was performed. After using an oligo microarrays representing 24,650 human genes and 37,580 gene transcripts, 6,154 genes remained after pre-processing and filtering. This resulted in a total of 993 up-regulated genes with 189 genes for progesterone and 255 genes for Mifepristone. The 550 down regulated genes were distributed with 256 genes for progesterone, 127 genes for RU 486. The results showed that genes presenting the epidermal growth factor (EGF)/MAP-kinase pathway were significantly over-represented by progesterone treatment, whereas, by Mifepristone treatment genes involved in the p53 pathway were also up-regulated (data not shown). These genes may be interesting as potential new therapeutic targets in endometrial hyperplasia and endometrial cancer, as candidate genes for therapy response or as candidate markers for tumor progression. 20 samples, 4 different condition groups with 5 replicates for each group, linear factorial experimental design. Short time (4hrs) dose response to progesterone and Mifepristone in combination and alone. Only 18 samples are represented in this Series.

ORGANISM(S): Homo sapiens

SUBMITTER: Anne Ørbo 

PROVIDER: E-GEOD-14713 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml

Similar Datasets

Transcriptomics Effects of high concentrations of progesterone and Mifepristone: a gene expression study of endometrial cancer cells
2009-02-05 | GSE14713 | GEO
Transcriptomics Progesterone-mediated gene expression in the human endometrial stromal compartment during the implantation window
2014-07-16 | E-GEOD-59447 | biostudies-arrayexpress
Transcriptomics Premature progesterone rise
2010-12-21 | E-GEOD-19959 | biostudies-arrayexpress
Transcriptomics RNA-Seq of human cell lines Ishikawa, MCF7 and T47D treated with estrogen, progesterone and their antagonists
2012-01-05 | E-MTAB-822 | biostudies-arrayexpress
Transcriptomics Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial
2024-07-15 | GSE252145 | GEO
Clinical Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome
| 2406005 | ecrin-mdr-crc
Transcriptomics Adiposity alters protective mechanisms of progesterone through dysregulation of endometrial metallothionein expression
2024-04-19 | GSE240926 | GEO
Clinical Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome
| 2047003 | ecrin-mdr-crc
Transcriptomics The impact of progesterone levels and timing of progesterone exposure on human endometrial receptivity
2020-03-12 | GSE146777 | GEO
Transcriptomics Transciption profiling of human endometrial biopsies taken on the day of oocyte retrieval in stimulated IVF cycles with 1 or 2 embryos replaced on day 3 in the same cycle
2009-11-16 | E-GEOD-13027 | biostudies-arrayexpress